HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease

Keyphrases

• Multicenter Clinical Trial 100%
• Inflammatory Biomarkers 100%
• HLA-DR Expression 100%
• Ocular Surface Disease 100%
• Impression Cytology 100%
• Minimally Invasive 50%
• Repeatability 50%
• Ocular Surface 50%
• Dry Eye 50%
• Standard Operating Procedures 50%
• Translational Research 33%
• HLA-DR 33%
• Cytological Samples 33%
• Clinical Trials 16%
• Cell number 16%
• Normal Eyes 16%
• Treatment Efficacy 16%
• Distant Site 16%
• Relative Amount 16%
• Double-blind Randomized Clinical Trial 16%
• Cell Samples 16%
• Objective Biomarker 16%
• Storage Capability 16%
• Standardized Methodology 16%
• Biomarker Expression 16%
• Clinical Trial Research 16%
• Cold Storage 16%
• Refrigeration 16%
• Case Processing 16%
• Precision Reliability 16%

Medicine and Dentistry

• Clinical Trial 100%
• Biological Marker 100%
• Disease of Ocular Surface 100%
• Impression Cytology 85%
• Ocular Surface 42%
• Dry Eye 42%
• Eye Disease 28%
• Translational Research 28%
• Clinician 14%
• Combination Therapy 14%
• Randomized Clinical Trial 14%